BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 29396852)

  • 21. Circ-AKT3 inhibits clear cell renal cell carcinoma metastasis via altering miR-296-3p/E-cadherin signals.
    Xue D; Wang H; Chen Y; Shen D; Lu J; Wang M; Zebibula A; Xu L; Wu H; Li G; Xia L
    Mol Cancer; 2019 Nov; 18(1):151. PubMed ID: 31672157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth.
    Shen J; Lin H; Li G; Jin RA; Shi L; Chen M; Chang C; Cai X
    Oncotarget; 2016 May; 7(22):32088-99. PubMed ID: 27050071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop.
    Liu DL; Lu LL; Dong LL; Liu Y; Bian XY; Lian BF; Xie L; Wen D; Gao DM; Ke AW; Fan J; Wu WZ
    Theranostics; 2020; 10(8):3668-3683. PubMed ID: 32206115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FOXM1-Activated LINC01094 Promotes Clear Cell Renal Cell Carcinoma Development via MicroRNA 224-5p/CHSY1.
    Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
    Mol Cell Biol; 2020 Jan; 40(3):. PubMed ID: 31767633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
    Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z
    Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
    Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-19a and microRNA-19b promote the malignancy of clear cell renal cell carcinoma through targeting the tumor suppressor RhoB.
    Niu S; Ma X; Zhang Y; Liu YN; Chen X; Gong H; Yao Y; Liu K; Zhang X
    PLoS One; 2018; 13(2):e0192790. PubMed ID: 29474434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
    Lu GJ; Dong YQ; Zhang QM; Di WY; Jiao LY; Gao QZ; Zhang CG
    Int J Clin Exp Pathol; 2015; 8(5):5224-9. PubMed ID: 26191221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
    Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
    Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression.
    Zheng Z; Chen Z; Zhong Q; Zhu D; Xie Y; Shangguan W; Xie W
    Cancer Sci; 2021 Apr; 112(4):1443-1456. PubMed ID: 33453148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of miR-34a-5p can rescue disruption of the p53-DAPK axis to suppress progression of clear cell renal cell carcinoma.
    Jing ZF; Bi JB; Li Z; Liu X; Li J; Zhu Y; Zhang XT; Zhang Z; Li Z; Kong CZ
    Mol Oncol; 2019 Oct; 13(10):2079-2097. PubMed ID: 31294899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.
    Xiang W; Lv L; Zhou G; Wu W; Yuan J; Zhang C; Jiang G
    Cancer Med; 2020 Jun; 9(12):4251-4264. PubMed ID: 32281285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
    PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer.
    Fan Y; Ma X; Li H; Gao Y; Huang Q; Zhang Y; Bao X; Du Q; Luo G; Liu K; Meng Q; Zhao C; Zhang X
    Int J Cancer; 2018 Feb; 142(3):547-560. PubMed ID: 28921581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-483-5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma.
    Wang XG; Zhu YW; Wang T; Chen B; Xing JC; Xiao W
    Kaohsiung J Med Sci; 2021 Mar; 37(3):192-199. PubMed ID: 33151036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.
    Wotschofsky Z; Gummlich L; Liep J; Stephan C; Kilic E; Jung K; Billaud JN; Meyer HA
    PLoS One; 2016; 11(2):e0148746. PubMed ID: 26859141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feedback activation of GATA1/miR-885-5p/PLIN3 pathway decreases sunitinib sensitivity in clear cell renal cell carcinoma.
    Yao D; Xia S; Jin C; Zhao W; Lan W; Liu Z; Xiu Y
    Cell Cycle; 2020 Sep; 19(17):2195-2206. PubMed ID: 32783497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-24-1-5p Hinders Malignant Phenotypes of Clear Cell Renal Cell Carcinoma by Targeting SHOX2.
    Zhou J; Li P; Feng J; Wu Q; You S
    Biochem Genet; 2023 Oct; 61(5):2004-2019. PubMed ID: 36917325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
    Pengcheng S; Ziqi W; Luyao Y; Xiangwei Z; Liang L; Yuwei L; Lechen L; Wanhai X
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
    Okato A; Arai T; Yamada Y; Sugawara S; Koshizuka K; Fujimura L; Kurozumi A; Kato M; Kojima S; Naya Y; Ichikawa T; Seki N
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.